Aerie Pharmaceuticals, Inc. Increase Decrease In Operating Lease Liability
Aerie Pharmaceuticals, Inc. reported Increase Decrease In Operating Lease Liability of -$5.41 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2022-02-25
- Aerie Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2021 was -$5.41M.
- Aerie Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2020 was -$6.01M.
- Aerie Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2019 was -$4.68M.
| Period end | Increase Decrease In Operating Lease Liability 12 month |
|---|---|
| 2021-12-31 | -$5.41M 10-K · filed 2022-02-25 |
| 2020-12-31 | -$6.01M 10-K · filed 2022-02-25 |
| 2019-12-31 | -$4.68M 10-K · filed 2022-02-25 |